CSW at a glance
CSW INDUSTRIALS, INC. (CSW, SEC CIK 1624794) filed its latest 10-K annual report on May 26, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and Form 4 insider filings as recently as November 17, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended March 31, 2026 (FY2026), CSW INDUSTRIALS, INC. (CSW) reported revenue of $1.1 billion (up 23.3% from FY2025) and net income of $112.0 million. Diluted EPS was $6.70.
- As of September 30, 2026, 31 institutional investment managers tracked by SignalX reported holding CSW INDUSTRIALS, INC. (CSW) shares worth $2.0 billion in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Armes Joseph B on November 16, 2026 of 1,500 shares at $280.42 per share.
- In the last 90 days, CSW insiders reported 0 open-market purchases ($0) and 3 open-market sales ($1.3M) on Form 4, a net sale of $1.3M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2026
- $1.1B
- +23.3% vs prior year
- Insiders · 90 days
- 0 buys · 3 sells
- Net −$1.3M
- 13F holders
- 31 funds
- $2.0B · +2 vs prior quarter
- Latest 8-K
- Oct 29, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to risk factors from the Annual Report and subsequent SEC filings
- Unknown future risks could materially adversely affect business, financial condition, results of operations or cash flows
- Management’s assessment of currently immaterial risks remains subject to change
- Significant carried-forward risks include factors beyond management’s control affecting results of operations
Management Discussion & Analysis
- Quarterly revenue $361.4M, up 30.5% YoY from $277.0M, driven by acquisitions and 10.2% organic growth
- Operating margin 20.9% vs 20.5% YoY, while gross margin declined to 42.0% from 43.0%
- Best segment: Contractor Solutions revenue $285.8M, up 37.1%; worst: Engineered Building Solutions revenue $28.4M, down 11.1%
- Operating cash flow $171.0M vs $122.5M; cash balance $37.2M vs $33.8M at March 31, 2026
- Outlook: strong fiscal 2027 balance sheet; headwinds from elevated crude oil, freight, commodity costs and Asian supplier lead times
AI summary of the CSW 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Fiscal Q2 2026 results released for quarter ended September 30, 2026
- Investors should review Exhibit 99.1 for revenue, earnings, margins and guidance details
Item EX-99.1: Item EX-99.1
- Fiscal Q2 revenue $361.4M, up 30.5%, with 20.3% inorganic growth and 10.2% organic growth
- Adjusted EPS $3.66, up 23.6%, while adjusted EBITDA rose 32.6% to $96.7M
Item 8.01: Other Events
- J. Kent Sweezey retired from the Board after reaching the mandatory retirement age
- Darron K. Ash appointed Chair of the Compensation and Talent Development Committee effective August 27, 2026
Item 5.07: Submission of Matters to a Vote of Security Holders
- 91.40% shareholder participation, with 14,895,264 shares represented
- All seven director nominees elected for one-year terms ending in 2027
Item 2.02: Results of Operations and Financial Condition
- Fiscal first-quarter results ended June 30, 2026 announced on July 30, 2026
- Investor focus: operating performance, outlook and segment trends detailed in Exhibit 99.1
Item EX-99.1: Item EX-99.1
- Fiscal 2027 Q1 revenue $350.6M, up 33.0%, with acquisitions contributing 27.7% and organic growth contributing 5.3%
- Adjusted EPS $3.84, up 34.6%, while adjusted EBITDA rose 47.8% to $101.6M
AI summaries of CSW 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for CSW
Don't miss the next CSW filing
- Alerts as it files. A push when CSW files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut CSW, by share count.
- Ask anything. An AI agent that reads every CSW filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Armes Joseph B | Sell | Nov 16, 2026 | 1,500 | $280.42 |
| Armes Joseph B | Sell | Oct 15, 2026 | 1,500 | $287.04 |
| Alverson Luke | A | Oct 1, 2026 | 815 | - |
| Sullivan Don | F | Oct 1, 2026 | 572 | $292.38 |
| Garde Danielle | A | Oct 1, 2026 | 815 | - |
| Garde Danielle | F | Oct 1, 2026 | 399 | $292.38 |
| UNDERWOOD JEFF | A | Oct 1, 2026 | 1,404 | - |
| WANG FANG | F | Oct 1, 2026 | 134 | $292.38 |
Financial SummaryXBRL
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $878.3M | $1.1B |
| Gross Profit | - | $393.3M | $453.7M |
| Operating Income | $159.1M | $181.2M | $168.5M |
| Net Income | $101.6M | $136.7M | $112.0M |
| Gross Margin | - | 44.8% | 41.9% |
| Op. Margin | - | 20.6% | 15.6% |
| Net Margin | - | 15.6% | 10.4% |
| Balance Sheet | |||
| Total Assets | - | $1.4B | $2.3B |
| Equity | - | $1.1B | $1.1B |
| ROE | - | 12.7% | 10.7% |
| Per Share | |||
| EPS | $6.52 | $8.38 | $6.70 |
| Cash Flow | |||
| Operating CF | $164.3M | $168.4M | $149.7M |
Source: XBRL data in CSW INDUSTRIALS, INC. (CSW)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate CSW share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 31 | $1.96B |
| Q2 2026 | 29 | $1.93B |
| Q1 2026 | 30 | $1.83B |
| Q4 2025 | 28 | $2.15B |
| Q3 2025 | 30 | $1.70B |
| Q2 2025 | 30 | $1.96B |
| Q1 2025 | 28 | $1.29B |
| Q4 2024 | 27 | $1.37B |
- Citadel Advisors LLC+23.0K (+281%)
- Raymond James Financial+9.6K (+9%)
- Dimensional Fund Advisors+5.5K (+2%)
- Goldman Sachs Group+4.6K (+2%)
- Invesco Ltd+3.3K (+8%)
- Morgan Stanley−59.3K (-10%)
- BlackRock−47.5K (-2%)
- Ameriprise Financial−24.1K (-38%)
- Vanguard Portfolio Management LLC−21.7K (-2%)
- Wells Fargo & Co−13.4K (-19%)
- Bridgewater Associates LP+11.0K
- Franklin Resources+1.1K
- Marex Group plc+862
- FMR LLC (Fidelity)−2.7K
Source: 13F-HR filings on SEC EDGAR (aggregated from 233 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
CSW filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 17, 2026 | - | - | - |
| 8-K | Oct 29, 2026 | - | Analysis | - |
| 10-Q | Oct 29, 2026 | Sep 30, 2026 | Analysis | |
| 4 | Oct 16, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Sep 16, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 4 | Aug 31, 2026 | - | - | - |
| 8-K | Aug 31, 2026 | - | Analysis | - |
| 4 | Aug 17, 2026 | - | - | - |
| 4 | Aug 11, 2026 | - | - | - |
| 4 | Aug 5, 2026 | - | - | - |
| 4 | Aug 5, 2026 | - | - | - |
| 4 | Aug 5, 2026 | - | - | - |
| 4 | Aug 5, 2026 | - | - | - |
Related Health Care companies
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
- ACHC · Acadia Healthcare Company IncServices-Specialty Outpatient Facilities, NEC
CSW SEC filings: frequently asked questions
Are CSW insiders buying or selling?
In the last 90 days, CSW INDUSTRIALS, INC. (CSW) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $1.3 million by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold CSW stock?
As of September 30, 2026, the largest CSW INDUSTRIALS, INC. (CSW) holders among the 13F filers tracked by SignalX were BlackRock ($696.9 million), Vanguard Portfolio Management LLC ($249.7 million), Vanguard Capital Management LLC ($211.5 million), State Street Corp ($193.2 million), Morgan Stanley ($148.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was CSW's revenue in fiscal year 2026?
For the fiscal year ended March 31, 2026 (FY2026), CSW INDUSTRIALS, INC. (CSW) reported revenue of $1.1 billion (up 23.3% from FY2025) and net income of $112.0 million. Diluted EPS was $6.70. The figures come from the XBRL data in the 10-K.
What did CSW report in its latest 8-K?
CSW INDUSTRIALS, INC. (CSW) filed an 8-K on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal Q2 2026 results released for quarter ended September 30, 2026.
What are the latest CSW SEC filings?
CSW INDUSTRIALS, INC. (CSW) filed its latest 10-K annual report on May 26, 2026, a 10-Q quarterly report on October 29, 2026, an 8-K current report on October 29, 2026 and a Form 4 insider filing on November 17, 2026.
What is CSW's SEC CIK number?
CSW INDUSTRIALS, INC. (CSW)'s SEC Central Index Key (CIK) is 1624794. EDGAR lists every CSW filing under that number.
Ask anything about CSW
The research agent reads CSW's filings, financials, insider trades and 13F holders, then answers with sources.